New York City, US · Angel
Martin Shkreli
Co-Founder
Latest rounds
- Turing PharmaceuticalsSeries A · $90MAug 2015
BacksPharmaBiotech
Rounds they were named in
- Rounds
- 1
- Led
- 0
- Disclosed
- $90M
- Active
- 2015
Turing PharmaceuticalsSeries A$90MUSJoined · historical
Rounds where a report named this person rather than a firm, matched on name: read it as a strong hint, not proof, since people share names.
Where they are named on record
Filings
- SEC Form D · Company raisingGodel Systems, Inc.Executive Officer, Directorsince 2017
- SEC Form D · Company raisingTuring Pharmaceuticals AGExecutive Officer, Directoron 2 filings · since 2015
- SEC Form D · Company raisingKindly, IncDirectorsince 2015
- SEC Form D · Company raisingRetrophin, Inc.Chief Executive Officer and Directorsince 2013
- SEC Form D · Hedge fundMSMB CONSUMER LPMartin Shkreli is the Managing Member of MSMB Isotope GP LLC, the General Partner of the Issuer.since 2011
- SEC Form D · Hedge fundMSMB ISOTOPE FUND LPMartin Shkreli is the Managing Member of MSMB Isotope GP LLC, the General Partner of the Issuer.since 2011
Each row is a document a firm filed with a regulator: somebody signed it, and it carries a date.
Hear them before you pitch them
Martin Shkreli: Big Pharma's Blind Spot, Betting Against Quantum & What Prison Taught Him
WithMartin Shkreli
About this episode
(0:00) Martin Shkreli joins the Besties! (0:55) Why quantum computing is a one-trick business and why he's betting against it (7:42) The drugs big pharma sells too cheap and his journey from hedge fund trader to pharma (11:37) AI, drug discovery, and who actually wins (21:32) Brilliance and… More on the show's page
Listen on
Apple PodcastsThe show's page
Leopold Sold, Ferrari Undefeated, Martin Shkreli Joins | Guillaume Verdon, Lulu Meservey, Michael Kim, Joon Sung Park, Karan Kunjur, Vlad Tenev
WithGuillaume VerdonMartin ShkreliVlad Tenev
About this episode
(00:17) - Leopold Sold (12:14) - Martin Shkreli discusses the leveraged collapse of a major AI-focused hedge fund, explaining how forced liquidation, predatory short-selling, and excessive position sizing can rapidly destroy a portfolio. The former hedge fund manager and pharmaceutical executive… More on the show's page
Listen on
Apple PodcastsThe show's pageMartin Shkreli Breaks Down the Collapse of Situational Awareness
WithMartin Shkreli
About this episode
This is our full interview with Martin Shkreli. We discussed the collapse of Leopold Aschenbrenner's AI-focused hedge fund, why leverage turns market corrections into disasters, how Wall Street unwinds massive positions, why AI infrastructure stocks sold off despite record AI demand, whether the… More on the show's page
Listen on
Apple PodcastsThe show's page
Martin Shkreli on AI, Pharma, and What Actually Matters
WithMartin Shkreli
About this episode
Erik Torenberg speaks with Martin Shkreli, American investor and businessman, about how he sees the AI landscape, from OpenAI to Anthropic, and what actually matters beyond the hype. They also talk through the future of computing, the limits of “vibe coding,” and why biotech and pharma remain some… More on the show's page
Listen on
Apple PodcastsThe show's pageThe Great Peptide Debate with Martin Shkreli & Max Marchione
WithMartin ShkreliMax Marchione
About this episode
This is our full interview with Martin Shkreli and Max Marchione, recorded live on TBPN. We discuss the sharp divide between biotech orthodoxy and the rising peptide movement, unpack the fight over whether compounds like BPC-157 are dangerous gray-market hype or promising under-researched tools… More on the show's page
Listen on
Apple PodcastsThe show's pageThe Great Peptide Debate, SpaceX's Lunar Mass Driver, AI Coming for Zuck's Job | Martin Shkreli & Max Marchione, Mitchell Green, Shane Hegde, Dr. Adam Oskowitz, Robin Vince, David Senra
WithMartin ShkreliMax MarchioneMitchell Green
MentionsLead Edge Capital
About this episode
Sign up for TBPN’s daily newsletter at TBPN.com (01:22) - SpaceX's Lunar Mass Driver (41:12) - 𝕏 Timeline Reactions (54:37) - AI Coming for Zuck's Job (58:17) - The Great Peptide Debate w/ Martin Shkreli & Max Marchione. Martin Shkreli, often referred to as the "Pharma Bro," is an… More on the show's page
Listen on
Apple PodcastsThe show's page
Mentioned in
Episodes that name Martin Shkreli in their description, which is not the same as being on them.
10 of The Wildest Hot Takes From the All-In Summit 2026
MentionsAltimeterChamath PalihapitiyaDavid FriedbergDavid SacksElon MuskJason Calacanis
About this episode
The All-In Summit returned to Los Angeles this year with one of its biggest lineups yet: Elon Musk, Jensen Huang, Satya Nadella, Gwynne Shotwell, Jared Isaacman, Brad Gerstner, Bill Gurley, Dina Powell McCormick, Jake Paul, Nick Shirley, Blake Scholl, Martin Shkreli and more, alongside hosts… More on the show's page
Listen on
Apple PodcastsThe show's pageWeekly Recap: CEO Affair at Coldplay Concert, Elon Musk's AI Girlfriend, Cognition Acquires Windsurf
MentionsElon MuskJeff WangMartin Shkreli
About this episode
(00:00) - Intro (00:03) - Astronomer CEO Affair at Coldplay Concert (11:11) - The Steelman for Grok's Vulgar Anime Mode (29:31) - Cognition Acquires Windsurf (01:20:14) - Jeff Wang (Windsurf) & Scott Wu (Cognition) (01:32:19) - Windsurf Chaos Aftermath Breakdown (01:41:27) -… More on the show's page
Listen on
Apple PodcastsThe show's page
Crypto Roundtable: Shkreli's new web3 project, ETH merge, Gensler goes after DeFi protocols | E1542
MentionsVinny LinghamMartin ShkreliSunny Madra
About this episode
J+M are joined by Sunny Madra and Vinny Lingham for another crypto roundtable! They cover the following topics: Shkreli's new web3 project (1:50), distributed computing projects (16:08), ETH merge (38:00), Gensler's comments (44:57), and more! (0:00) Molly tees up today's roundtable guests!… More on the show's page
Listen on
Apple PodcastsThe show's page
Episodes of the shows we follow, matched by name. Not them? Tell us.
Find people like Martin
Filter every partner and angel by firm, kind, market and whether we watched them invest. Free with an account.